Triple versus dual antiplatelet therapy of cilostazol or sarpogrelate with aspirin and clopidogrel after percutaneous coronary intervention: a retrospective cohort study using Korean National Health Insurance Claim Database

被引：0
|
作者：
Noh, Yoojin [1 ]
Lee, Jimin [1 ]
Shin, Sooyoung [1 ]
Lee, Sukhyang [1 ]
机构：
[1] Ajou Univ, Coll Pharm, Suwon 441749, South Korea
来源：
PHARMACOTHERAPY | 2015年 / 35卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
344
引用
收藏
页码：E260 / E260
页数：1
相关论文
共 50 条
  • [1] Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database
    Noh, Yoojin
    Lee, Jimin
    Shin, Sooyoung
    Lim, Hong-Seok
    Bae, Soo Kyung
    Oh, Euichul
    Kim, Grace Juyun
    Kim, Ju Han
    Lee, Sukhyang
    PLOS ONE, 2016, 11 (03):
  • [2] Triple versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Adding Cilostazol to Aspirin and Clopidogrel?
    Niazi, Asfandyar K.
    DiNicolantonio, James J.
    Lavie, Carl J.
    O'Keefe, James H.
    Meier, Pascal
    Bangalore, Sripal
    CARDIOLOGY, 2013, 126 (04) : 233 - 243
  • [3] Twelve versus 30 month dual antiplatelet therapy after percutaneous coronary intervention using national health insurance review & assessment (HIRA) database
    Lee, K. M.
    Kim, M. H.
    Choi, S. Y.
    Kim, S. J.
    Jin, C. D.
    Guo, L. Z.
    Serebruany, V. L.
    EUROPEAN HEART JOURNAL, 2016, 37 : 667 - 667
  • [4] Stroke rate after twelve versus 30 month dual antiplatelet therapy in percutaneous coronary intervention patients using Korean National Health Insurance Service (NHIS)
    Lee, K. M.
    Kim, M. H.
    Choi, S. Y.
    Kim, S. J.
    Kim, H. B.
    Kang, S. Y.
    Serebruany, V.
    EUROPEAN HEART JOURNAL, 2017, 38 : 836 - 836
  • [5] Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement database
    Latry, Philippe
    Martin-Latry, Karin
    Lafitte, Marianne
    Peter, Claude
    Couffinhal, Thierry
    EUROINTERVENTION, 2012, 7 (12) : 1413 - 1419
  • [6] Duration and clinical outcome of dual antiplatelet therapy after percutaneous coronary intervention: a retrospective cohort study using a medical information database from Japanese hospitals
    Yokoi, Hiroyoshi
    Oda, Eisei
    Kaneko, Kazuki
    Matsubayashi, Kenta
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2022, 37 (03) : 465 - 474
  • [7] Duration and clinical outcome of dual antiplatelet therapy after percutaneous coronary intervention: a retrospective cohort study using a medical information database from Japanese hospitals
    Hiroyoshi Yokoi
    Eisei Oda
    Kazuki Kaneko
    Kenta Matsubayashi
    Cardiovascular Intervention and Therapeutics, 2022, 37 : 465 - 474
  • [8] Stroke and mortality rate for long-term antiplatelet therapy in percutaneous coronary intervention patients using korean national health insurance service (NHIS) database
    Kim, M. H.
    Lee, K. M.
    Kim, S. J.
    Choi, S. Y.
    Kim, J. K.
    Kim, S. W.
    Park, J. S.
    Park, K. I.
    EUROPEAN HEART JOURNAL, 2018, 39 : 694 - 694
  • [9] Frequency of the Use of Low- Versus High-Dose Aspirin in Dual Antiplatelet Therapy After Percutaneous Coronary Intervention (from the Dual Antiplatelet Therapy Study)
    Matteau, Alexis
    Yeh, Robert W.
    Kereiakes, Dean
    Orav, E. John
    Massaro, Joseph
    Steg, P. Gabriel
    Normand, Sharon-Lise
    Cutlip, Donald E.
    Mauri, Laura
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (07): : 1146 - 1152
  • [10] Comment on "Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement database"
    Carvalho, Henrique Cyrne
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2012, 31 (7-8) : 543 - 544
12345